Literature DB >> 2364306

The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions.

L Greiff1, U Pipkorn, U Alkner, C G Persson.   

Abstract

A 'nasal pool' (NP) device, a compressible plastic container with an adapted nozzle, was used to perform a continuous 10-min nasal provocation and lavage. This novel technique brings known concentrations of agents into contact with a large and defined area of the nasal mucosal surface for extended periods of time. Simultaneously, the surface exudations/secretions of the same nasal mucosa are effectively sampled by the NP fluid. A concentration-response study of histamine (80, 400 and 2000 micrograms/ml) was performed in 12 normal subjects on three different occasions. Exudation of plasma albumin into the lavage fluid was measured to quantitate the histamine-induced airway inflammation. The effect of the dwell time on exudation was examined using histamine (400 micrograms/ml) instilled in the nasal cavity for time periods from 10 sec to 10 min. The time course of histamine-induced plasma exudation response was studied by exposing the mucosa to histamine (400 micrograms/ml) for 12 min, with the NP renewed every minute. Allergen-provocations were performed in subjects with hay fever and TAME-esterase activity in the returned lavage fluid was determined to indicate the degree of response. Histamine produced a concentration-dependent increase in albumin levels in the NP fluid; 123.3 +/- 25.6, 213.8 +/- 19.7 and 430.2 +/- 32.0 micrograms/ml (mean +/- s.e.m.), respectively. The time-course study demonstrated that plasma exudation into the lumen occurred promptly and that the exudation response reached a maximum after exposure to histamine for 6-10 min. The dwell-time experiments supported this finding. After 10 min the exudation appeared to decline despite the continued presence of histamine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364306     DOI: 10.1111/j.1365-2222.1990.tb02680.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  27 in total

1.  The use of the nose to study the inflammatory response of the respiratory tract.

Authors:  C G Persson; C Svensson; L Greiff; M Anderson; P Wollmer; U Alkner; I Erjefält
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

2.  Absorption of 51Cr EDTA across the human nasal airway barriers in the presence of topical histamine.

Authors:  L Greiff; P Wollmer; U Pipkorn; C G Persson
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

Review 3.  Humoral First-Line Mucosal Innate Defence in vivo.

Authors:  Carl Persson
Journal:  J Innate Immun       Date:  2020-03-23       Impact factor: 7.349

4.  Changes in nasal lavage fluid due to formaldehyde inhalation.

Authors:  K Pazdrak; P Górski; A Krakowiak; U Ruta
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

5.  Effect of ipratropium on nasal reactivity to histamine and eosinophil influx in perennial allergic rhinitis.

Authors:  P Górski; K Pazdrak; U Ruta
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis.

Authors:  Lena Uller; Cecilia Ahlström Emanuelsson; Morgan Andersson; Jonas S Erjefält; Lennart Greiff; Carl G Persson
Journal:  Respir Res       Date:  2010-05-09

7.  Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids.

Authors:  Violetta M Piotrowska; Wojciech J Piotrowski; Zofia Kurmanowska; Jerzy Marczak; Paweł Górski; Adam Antczak
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

8.  Effects of nicotine on the human nasal mucosa.

Authors:  L Greiff; P Wollmer; I Erjefält; M Andersson; U Pipkorn; C G Persson
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

9.  Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA.

Authors:  L Greiff; P Wollmer; C Svensson; M Andersson; C G Persson
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

10.  Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold.

Authors:  L Greiff; M Andersson; A Akerlund; P Wollmer; C Svensson; U Alkner; C G Persson
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.